Platform Comparison for Evaluation of ALK Protein Immunohistochemical Expression, Genomic Copy Number and Hotspot Mutation Status in Neuroblastomas

ALK is an established causative oncogenic driver in neuroblastoma, and is likely to emerge as a routine biomarker in neuroblastoma diagnostics. At present, the optimal strategy for clinical diagnostic evaluation of ALK protein, genomic and hotspot mutation status is not well-studied. We evaluated AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Benedict, Kuick, Chik Hong, Lim, Malcolm, Venkataraman, Kavita, Tennakoon, Chandana, Loh, Eva, Lian, Derrick, Leong, May Ying, Lakshmanan, Manikandan, Tergaonkar, Vinay, Sung, Wing-Kin, Soh, Shui Yen, Chang, Kenneth T. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154751/
https://www.ncbi.nlm.nih.gov/pubmed/25188507
http://dx.doi.org/10.1371/journal.pone.0106575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154751/
https://www.ncbi.nlm.nih.gov/pubmed/25188507
http://dx.doi.org/10.1371/journal.pone.0106575

Ejemplares similares